Company profile

Current Health

The Clinical Operating System for Care Beyond the Hospital

Remote Patient Monitoring & WearablesAcquired stage

Company profile

About Current Health

Current Health is a healthcare technology company that provides the safety infrastructure and clinical support services needed to deliver advanced therapies and high-acuity care beyond traditional hospital settings. The company serves health systems, community practices, and life sciences companies with an integrated platform combining FDA-cleared passive monitoring devices, AI-enabled clinical deterioration detection, and a 24/7 clinical command center staffed by ED and ICU-trained nurses. The company's proprietary wearable device passively monitors critical vitals including respiratory rate, heart rate, SpO2, skin temperature, and activity levels. Their machine learning algorithms analyze this biometric data to detect adverse events like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) hours earlier than standard clinical observation, enabling proactive intervention. Current Health has supported over 80,000 patients and facilitated the shift of $800 million in therapy spend to home and community settings. Current Health works across four primary care models: supporting life sciences companies with pharmacovigilance and real-world evidence generation for clinical trials; enabling health systems to scale outpatient CAR-T and bispecifics programs; providing turnkey infrastructure for community practices to deliver advanced therapies; and launching high-acuity hospital-at-home programs. The company has published 54 peer-reviewed papers and abstracts and has been selected for FDA's READI-Home Innovation Challenge for their CRS detection solution.

Company description Current Health official website

Mission. We equip providers, healthcare organizations and life sciences to manage the complexity of advanced therapies and high-acuity care in the real world—driving better provider, patient & caregiver experiences, lower total cost of care and greater scale.

Primary marketRemote Patient Monitoring & Wearables
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Current Health?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • bispecific antibody therapy complications
  • CAR-T therapy complications
  • Cytokine Release Syndrome (CRS)
  • general clinical deterioration
  • ICANS (neurotoxicity)
  • infectious complications
  • sepsis

Who it serves

  • Academic Medical Centers
  • Community Hospitals
  • Health Systems
  • Life Sciences
  • MSOs
  • Pharma
  • Physician Groups

Deployment & integration

Cloud Saas · Embedded · Hybrid deployment with recorded integration context.

Recorded integration context: Cerner, Epic, Meditech.

Geographic context

Markets50 state nursing licensure · United States
Company sourceOfficial website

Company milestones

Platform expansion

Partnership with Cardinal Health Velocare to scale Hospital-at-Home announced. 54 peer-reviewed publications in last 36 months. Mass General Brigham achieved 200% program growth in 15 months. 80,000 patients cared for on platform.

Partnerships

Recorded partners

  • Cardinal Health Velocare
  • Mass General Brigham
  • Sarah Cannon Cancer Institute
  • UMass Memorial Health
  • Virtua Health

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

24/7 Clinical Command Center

Around-the-clock monitoring by ED and ICU-trained RNs licensed in all 50 states with AI-powered efficiency

Service · Cloud SaaSCompany source

AI-Enabled Care Operations

AI-powered staff scheduling, route planning, and service coordination for scalable high-acuity home care

Software · Cloud SaaSCompany source

CRS Detection AI

Machine learning for early cytokine release syndrome detection

Model · EmbeddedCompany source

CRS Detection AI Algorithm

Machine learning algorithm detecting cytokine release syndrome hours earlier than clinical observation

Software · Cloud SaaSCompany source

Current Health Platform

Clinical Operating System for Care Beyond the Hospital

Platform · HybridCompany source

Current Health Remote Monitoring Platform

AI-enabled remote management technology for high-cost therapies and complex care in ambulatory, home, and community settings

Platform · HybridCompany source

FDA-Cleared Passive Wearable

Proprietary upper-arm wearable for passive monitoring of critical vitals without patient burden

Device · EmbeddedCompany source

FDA-Cleared Wearable Device

Proprietary upper-arm wearable for passive biometric monitoring

Device · EmbeddedCompany source

ICANS Assessment Service

Virtual neurotoxicity assessments for CAR-T safety

Service · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

90%+ of CAR-T therapies shifted to outpatient

Sarah Cannon Cancer Institute

1,200 bed days saved in first 100 patients

Sarah Cannon Cancer Institute

25,000+ bed days saved

Mass General Brigham

Average daily census of 49 patients

Mass General Brigham Hospital at Home

Lower-than-average readmission rates

Mass General Brigham

Zero unexpected mortality

Mass General Brigham

Hours earlier CRS detection than standard of care

Clinical research

2.3 minute alarm response time

Clinical command center

200% growth in 15 months

Mass General Brigham program expansion

Mass General Brigham

Scaled Hospital at Home program to become one of the nation's largest, demonstrating clinical safety and scalability

25,000+ bed days saved, average daily census of 49+ patients, lower-than-average readmission rate, zero unexpected mortality, 200% growth in 15 months

Sarah Cannon Cancer Institute

Shifted CAR-T therapies from inpatient to outpatient settings to reduce bed dependency and improve patient experience

90%+ of CAR-T therapies treated outpatient, 1,200 bed days saved in first 100 patients, 67% of patients stayed home for 72+ hours

UCSF Medical Center

24/7 nurse oversight and remote nurse triage for infusion and apheresis patients

Continuous patient monitoring with dedicated trained staff support

UMass Memorial Health

Implemented Hospital at Home program using Current Health technology for home-based acute care

Virtua Health

Deployed Hospital at Home program with real-time patient monitoring and data documentation

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Christopher McGhee

Christopher McGhee

CEO & Co-Founder

LinkedIn

Christopher McGhee

CEO & Co-Founder

LinkedIn

06 · Company updates

Updates from Current Health

Recent articles published on Current Health's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Remote Patient Monitoring & Wearables

Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon